Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Evolent Health, Inc Class A Common Stock (NY: EVH )

12.54 -0.06 (-0.48%)
Official Closing Price Updated: 7:00 PM EST, Jan 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Evolent Health, Inc Class A Common Stock

< Previous 1 2 3 4 Next >
Simulations Plus Stock Scores Composite Rating Move Up To 96
The IBD SmartSelect Composite Rating for Simulations Plus stock rose from 94 to 96 Wednesday. The medical software stock has 94 RS Rating. 
Via Investor's Business Daily
Evolent Expands Its Portfolio For Musculoskeletal Conditions With This Deal
Via Benzinga
Bear Market Rally Lifts HealthCare Stocks Off Bottom
Clearly we are in a biotech bear market with both diagnostics and vaccine revenues stalled. If gene editing stocks cannot offer breakthrough clinical news then stick with large cap biopharma. 
Via Talk Markets
4 Analysts Have This to Say About Evolent Health
Evolent Health (NYSE:EVH) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Privia Health Stock Among The Few That've Risen This Month
Privia Health is trying to complete a cup without handle with a 29.07 entry. See if it clears the breakout price in above average volume. 
Via Investor's Business Daily
Canaccord Genuity Maintains Buy Rating for Evolent Health: Here's What You Need To Know
Canaccord Genuity has decided to maintain its Buy rating of Evolent Health (NYSE:EVH) and raise its price target from $40.00 to $45.00. Shares of Evolent Health are trading down 2.43% over the last 24... 
Via Benzinga
Recap: Evolent Health Q4 Earnings
Evolent Health (NYSE:EVH) reported its Q4 earnings results on Wednesday, February 23, 2022 at 04:02 PM. Here's what investors need to know about the announcement. Earnings... 
Via Benzinga
Why Evolent Health Shares Fell on Thursday
The company beat on Q1 earnings, but ... 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For March 30, 2022
Upgrades 
Via Benzinga
10 Biggest Price Target Changes For Friday
Jefferies cut the price target on MEI Pharma, Inc. (NASDAQ: MEIP) from $4 to $1. MEI Pharma shares fell 44.2% to $1.01 in pre-market trading. 
Via Benzinga
Tough Slogging Ahead for Investors, Diversification is Important
Speculative small/mid-cap biotech stocks hit new lows this past week with the XBI at a “triple bottom” about the $84 level only 10 points above the March 2020 lows. 
Via Talk Markets
Evolent Health 'Notification Award' Removes $82M Overhang, Notes Piper Sandler
In an SEC filing, Cook County named Evolent Health Inc (NYSE: EVH) the sole third-party administrator for CountyCare Health Plan from fiscal 2023 through fiscal 2025.... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Lantheus Holdings (NASDAQ:LNTH) stock rose 33.3% to $38.46 during Thursday's regular session. The current volume of 3.4 million shares is 876.7% of Lantheus... 
Via Benzinga
44 Stocks Moving In Thursday's Mid-Day Session
Gainers Indonesia Energy Corporation Limited (NYSE: INDO) shares climbed 66.7% to $12.55 following a 16% surge on Wednesday. Camber Energy, Inc. (NYSE: CEI) rose 45.2% to $0.... 
Via Benzinga
88 Biggest Movers From Yesterday
Gainers Cyren Ltd. (NASDAQ: CYRN) shares surged 118.9% to settle at $4.75 on Thursday. Cyren recently announced a $12 million private placement. Indonesia Energy Corporation... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers SCYNEXIS (NASDAQ:SCYX) shares inc... 
Via Benzinga
Earnings Outlook For Evolent Health
Evolent Health (NYSE:EVH) is set to give its latest quarterly earnings report on Wednesday, 2022-02-23. Here's what investors need to know before the announcement. Analysts... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2021
Upgrades Macquarie upgraded the previous rating for ZTO Express (Cayman) Inc (NYSE: 
Via Benzinga
Evolent Health (EVH) Q3 2021 Earnings Call Transcript
EVH earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
50 Biggest Movers From Yesterday
Gainers Jasper Therapeutics, Inc. (NASDAQ: JSPR) shares surged 105.1% to close at $14.79 on Wednesday after Oppenheimer initiated coverage on the stock with an Outperform rating... 
Via Benzinga
Here's Why Evolent Health Is Up 18.8% This Week
There's a rumor going around that Walgreens Boots Alliance wants to acquire the struggling administrative assistant business. 
Via The Motley Fool
Why Evolent Health Blasted 7% Higher on Thursday
Swirling buyout rumors continue to bring the bulls to the healthcare stock. 
Via The Motley Fool
Walgreens In Talks To Buy Evolent Health: Bloomberg
Walgreens Boots Alliance Inc (NASDAQ: WBA) is reportedly mulling an acquisition of Evolent Health Inc (NYSE: EVH). Citing people familiar with the matter, ... 
Via Benzinga
Evolent Health (EVH) Q2 2021 Earnings Call Transcript
EVH earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
NYSE: EVH Investor Notice: Update in Lawsuit Against Evolent Health, Inc.
San Diego, CA -- (SBWIRE) -- 05/06/2021 -- A lawsuit is pending for certain investors in Evolent Health, Inc. (NYSE: EVH) shares over alleged securities laws violations and NYSE: EVH investors should... 
Via SBWire
Topics Lawsuit
Exposures Financial Legal
Evolent Health (EVH) Q1 2021 Earnings Call Transcript
EVH earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Earnings Outlook For Evolent Health
Evolent Health (NYSE:EVH) releases its next round of earnings this Wednesday, May 05. Here is Benzinga's essential guide to Evolent Health's Q1 earnings report. What Are Earnings... 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.